First ever clinical trial of ‘classical drug’ to take place soon in India
NEW DELHI — Rashtriya Kamdhenu Aayog in Gujarat is gearing up for the clinical trial of ayurvedic medicine derived from panchgavya — cow’s milk, butter, ghee, dung and urine to treat COVID-19 patients in the state following protocols used to test allopathic medicines.
Confident about the effectiveness of cow urine and cow dung in treating certain ailments, the doctors in Gujarat are soon to try it on COVID-19 patients in 10 hospitals of the country, reports India.com.
In an interview with Ahmedabad Mirror, Dr Vallabh Kathiria, Chairman of Rashtriya Kamdhenu Aayog said, “During the clinical trials, the consenting patients would be
given this medicine and their progress documented scientifically. Comparison and analysis would be made as per modern medicine clinical trial norms. On completion of the multi-centre trials, a research paper would be published for peer review by the scientific and medical community.”
With Rajkot’s Civil Hospital to lead the trial, it will soon be followed by Ahmedabad and Surat and soon spread to rest of Indian with trials to be carried out in Vardha, Pune, Hyderabad and Jodhpur, according to reports.
“It is for the first time that a clinical trial of a ‘classical’ drug is being undertaken. The clinical trial will begin in 2-3 days and will have a 15-day protocol,” said Dr Hitesh Jani, Ex-Principal of Gujarat Ayurveda University.
Dr Vallabh Kathiria, speaking to India.Com asserted, “The effectiveness of Panchgavya medicine is known in India for centuries but not established in modern scientific context. Today, when the world is struggling to find a medicine for Covid-19, there is a distinct possibility that Panchgavya medicine may give us an effective treatment or cure.”